Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity. // Disease and Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S3050999826000253?dgcid=rss_sd_all
Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity. Disease and Therapeutics. https://www.sciencedirect.com/science/article/pii/S3050999826000253?dgcid=rss_sd_all
“Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity.” Disease and Therapeutics.
@article{article43298,
title = {Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity},
journal = {Disease and Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S3050999826000253?dgcid=rss_sd_all}
}